TheraRadar
← Back
Data updated: Mar 29, 2026

PARATEK PHARMS

Infectious DiseaseDermatology
Specialty

PARATEK PHARMS is a specialty pharmaceutical company focused on Infectious Disease, Dermatology. Key products include NUZYRA.

2017
Since
2
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

NUZYRA
omadacycline tosylate
2 indications · 2018
XHANCE
fluticasone propionate
Glucocorticoid receptor 1 indications · 2017

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NUZYRA 2025-03-31
Labeling
NUZYRA 2025-03-31
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology